These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8352253)

  • 1. Atherogenic lipids and lipoproteins in hemodialysis patients.
    Cheung AK; Wu LL; Kablitz C; Leypoldt JK
    Am J Kidney Dis; 1993 Aug; 22(2):271-6. PubMed ID: 8352253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
    Shoji T; Nishizawa Y; Kawagishi T; Tanaka M; Kawasaki K; Tabata T; Inoue T; Morii H
    Atherosclerosis; 1997 Jun; 131(2):229-36. PubMed ID: 9199276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.
    Güz G; Nurhan Ozdemir F; Sezer S; Işiklar I; Arat Z; Turan M; Haberal M
    Am J Kidney Dis; 2000 Oct; 36(4):826-36. PubMed ID: 11007687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein heterogeneity in end-stage renal disease.
    Joven J; Vilella E; Ahmad S; Cheung MC; Brunzell JD
    Kidney Int; 1993 Feb; 43(2):410-8. PubMed ID: 8441237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.
    Sentí M; Romero R; Pedro-Botet J; Pelegrí A; Nogués X; Rubiés-Prat J
    Kidney Int; 1992 May; 41(5):1394-9. PubMed ID: 1614054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipids and lipoproteins in schizophrenic patients with normal renal function treated with hemodialysis.
    Norbeck HE; Asaba H; Schulman A; Wetterberg L
    Artif Organs; 1983 Aug; 7(3):353-6. PubMed ID: 6578752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of potentially atherogenic triglyceride-rich lipoprotein particles].
    Alaupovic P; Blankenhorn DH
    Klin Wochenschr; 1990; 68 Suppl 22():38-42. PubMed ID: 2087077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
    Schwandt P
    Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lipid profile in maintenance haemodialysis].
    Jamoussi K; Ayedi F; Abida N; Kamoun K; Féki H; Chaabouni MN; Hammouda F; Bahloul I; Bellaj A; Hachicha J; Ellouz F
    Pathol Biol (Paris); 2005 May; 53(4):217-20. PubMed ID: 15850955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherogenic lipoproteins in end-stage renal disease.
    Shoji T; Ishimura E; Inaba M; Tabata T; Nishizawa Y
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S30-3. PubMed ID: 11576918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoproteins in children treated with continuous peritoneal dialysis.
    Querfeld U; LeBoeuf RC; Salusky IB; Nelson P; Laidlaw S; Fine RN
    Pediatr Res; 1991 Feb; 29(2):155-9. PubMed ID: 2014151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipids, lipoproteins and apolipoproteins AI, AII, and B in renal transplanted children: what risk for accelerated atherosclerosis?
    Goldstein S; Duhamel G; Laudat MH; Berthelier M; Hervy C; Tete MJ; Broyer M
    Nephron; 1984; 38(2):87-92. PubMed ID: 6433214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.
    Oyelola OO; Ajayi AA; Babalola RO; Stein EA
    J Natl Med Assoc; 1995 Feb; 87(2):113-8. PubMed ID: 7897682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.
    Zilversmit DB
    Clin Chem; 1995 Jan; 41(1):153-8. PubMed ID: 7813071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.
    Wilson DE; Chan IF; Buchi KN; Horton SC
    Metabolism; 1985 Jun; 34(6):551-8. PubMed ID: 3999977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of coffee consumption on plasma lipids, lipoproteins, and the development of aortic atherosclerosis in rhesus monkeys fed an atherogenic diet.
    Callahan MM; Rohovsky MW; Robertson RS; Yesair DW
    Am J Clin Nutr; 1979 Apr; 32(4):834-45. PubMed ID: 219678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics].
    Mudríková T; Tkác I; Takác M
    Vnitr Lek; 1994 Apr; 40(4):250-4. PubMed ID: 8184588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic dyslipidemia and atherosclerosis.
    Shepherd J
    Schweiz Med Wochenschr; 1994 Nov; 124(44):1933-7. PubMed ID: 7973520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.